Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-277833
Filing Date
2025-11-12
Accepted
2025-11-12 16:51:52
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d34778d424b5.htm 424B5 432463
2 GRAPHIC g34778g46v43.jpg GRAPHIC 59314
3 GRAPHIC g34778g61z05.jpg GRAPHIC 64153
  Complete submission text file 0001193125-25-277833.txt   603143
Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Filer) CIK: 0001980845 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 424B5 | Act: 33 | File No.: 333-283201 | Film No.: 251473831
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)